RSCM

Rock Springs Capital Management Portfolio holdings

AUM $1.6B
This Quarter Return
+20.34%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$4.16B
AUM Growth
+$4.16B
Cap. Flow
+$89.8M
Cap. Flow %
2.16%
Top 10 Hldgs %
34.47%
Holding
128
New
1
Increased
41
Reduced
25
Closed
8

Top Buys

1
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
$42.5M
2
AMLX icon
Amylyx Pharmaceuticals
AMLX
$30.5M
3
BAX icon
Baxter International
BAX
$20.1M
4
SGEN
Seagen Inc. Common Stock
SGEN
$16.5M
5
BPMC
Blueprint Medicines
BPMC
$15.5M

Top Sells

1
CVET
Covetrus, Inc. Common Stock
CVET
$35.1M
2
TLPH icon
Talphera
TLPH
$13.6M
3
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
$13.4M
4
ARVN icon
Arvinas
ARVN
$12.5M
5
OHPAU
Orion Acquisition Corp. Unit
OHPAU
$9.87M

Sector Composition

1 Healthcare 97.81%
2 Consumer Staples 0.83%
3 Industrials 0.36%
4 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
THRX
101
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
$2.18M 0.05% 437,329 – –
AUPH icon
102
Aurinia Pharmaceuticals
AUPH
$1.58B
$2.07M 0.05% 479,540 -586,868 -55% -$2.54M
SPRB
103
DELISTED
Spruce Biosciences, Inc. Common Stock
SPRB
$1.78M 0.04% 1,622,689 – –
LPTX icon
104
Leap Therapeutics
LPTX
$12M
$1.65M 0.04% 3,659,847 – –
SYRE icon
105
Spyre Therapeutics
SYRE
$996M
$1.54M 0.04% 3,413,906 – –
EPIX icon
106
ESSA Pharma
EPIX
$11.4M
$1.32M 0.03% 524,944 – –
SPRO icon
107
Spero Therapeutics
SPRO
$116M
$1.16M 0.03% 669,533 -101,177 -13% -$175K
FATE icon
108
Fate Therapeutics
FATE
$120M
$1.11M 0.03% 110,000 – –
TPST icon
109
Tempest Therapeutics
TPST
$44M
$947K 0.02% 823,654 – –
CGEN icon
110
Compugen
CGEN
$132M
$923K 0.02% 1,289,990 – –
VINC
111
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$910K 0.02% 891,719 -216,851 -20% -$221K
GOSS icon
112
Gossamer Bio
GOSS
$562M
$816K 0.02% 376,048 -1,210,914 -76% -$2.63M
TLPH icon
113
Talphera
TLPH
$11.1M
$715K 0.02% 316,460 -6,012,742 -95% -$13.6M
APLT icon
114
Applied Therapeutics
APLT
$71M
$453K 0.01% 596,680 -105,000 -15% -$79.8K
BCEL
115
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$290K 0.01% 362,530 -100,000 -22% -$80.1K
NUVB.WS icon
116
Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
NUVB.WS
$68M
$19.4K ﹤0.01% 134,028 – –
ARVN icon
117
Arvinas
ARVN
$568M
– – -280,100 Closed -$12.5M
ELVN icon
118
Enliven Therapeutics
ELVN
$1.2B
– – -842,402 Closed -$1.92M
EQRX
119
DELISTED
EQRx, Inc. Common Stock
EQRX
– – -1,000,000 Closed -$4.95M
OHPAU
120
DELISTED
Orion Acquisition Corp. Unit
OHPAU
– – -1,000,000 Closed -$9.87M
JYAC
121
DELISTED
Jiya Acquisition Corp. Class A Common Stock
JYAC
– – -206,200 Closed -$2.06M
PHAS
122
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
– – -2,719,074 Closed -$479K
BLSA
123
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
– – -309,000 Closed -$3.1M
CVET
124
DELISTED
Covetrus, Inc. Common Stock
CVET
– – -1,678,800 Closed -$35.1M
1 2 3 4
5